Fecal Microbiota Transplantation(MD Anderson Cancer Center)(Fecal Microbiota Transplantation(MD Anderson Cancer Center))

概要

基本信息

药物类型

粪菌移植

别名-

靶点-

作用方式

调节剂

作用机制

细菌替代物、微生物调节剂

治疗领域

肿瘤免疫系统疾病血液及淋巴系统疾病

在研适应症

B细胞淋巴瘤

非在研适应症-

原研机构

The University of Texas MD Anderson Cancer Center

在研机构

The University of Texas MD Anderson Cancer Center

非在研机构-

权益机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

4

项与 Fecal Microbiota Transplantation(MD Anderson Cancer Center) 相关的临床试验

ChiCTR2400083998

/ Suspended早期临床1期IIT

Efficacy and safety of fecal microbiota transplantation in treatment of Autism spectrum disorder:a prospective single-center intervention study

开始日期2024-05-10

申办/合作机构-

ChiCTR2400083251

/ SuspendedN/AIIT

Safety and efficacy of fecal microbiota transplantation in the treatment of idiopathic membranous nephropathy: a randomized controlled clinical trial

开始日期2024-04-25

申办/合作机构-

NCT06218602

/ Recruiting临床2期IIT

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

To find out if adding treatment with fecal microbiota transplantation (FMT) is effective at treating gut-related side effects of antibiotic treatment in participants who are receiving standard therapy with anti-CD19 chimeric antigen receptor T-cell (CAR-T cell) therapy.

开始日期2024-02-19

申办/合作机构

The University of Texas MD Anderson Cancer Center

100 项与 Fecal Microbiota Transplantation(MD Anderson Cancer Center) 相关的临床结果

登录后查看更多信息

100 项与 Fecal Microbiota Transplantation(MD Anderson Cancer Center) 相关的转化医学

登录后查看更多信息

100 项与 Fecal Microbiota Transplantation(MD Anderson Cancer Center) 相关的专利（医药）

登录后查看更多信息

100 项与 Fecal Microbiota Transplantation(MD Anderson Cancer Center) 相关的药物交易

登录后查看更多信息